AMGEN 20180244 (OCEAN(a))

AMGEN 20180244 (OCEAN(a))

Patient Information

OCEAN(a) Outcome- A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a).

Learn More

Study Contact: cardiovascularresearch@conehealth.com

Clinical Trial Categories

• Cholesterol/Diabetes/Hypertension